Biomedical Engineering Reference
In-Depth Information
10. Couchman JR. (2010) Transmembrane signaling proteogly-
cans. Annu. Rev. Cell Dev. Biol. 26, 89-114.
11. Shintani Y, Takashima S, Asano Y, Kato H, Liao Y, Yamazaki
S, et al. (2006) Glycosaminoglycan modification of neuropilin-
1 modulates VEGFR2 signaling. EMBO J. 25(13), 3045-3055.
12. Esko JD, Selleck SB. (2002) Order out of chaos: assembly of
ligand binding sites in heparan sulfate. Annu. Rev. Biochem.
71, 435-471.
13. Nadanaka S, Kitagawa H. (2008) Heparan sulphate bio-
synthesis and disease. J. Biochem. 144(1), 7-14.
14. Lindahl U, Li JP. (2009) Interactions between heparan sulfate
and proteins-design and functional implications. Int. Rev. Cell
Mol. Biol. 276, 105-159.
15. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S,
Rosen SD. (2002) Cloning and characterization of two extrac-
ellular heparin-degrading endosulfatases in mice and humans.
J. Biol. Chem. 277(51), 49175-49185.
16. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM,
Emerson CP., Jr. (2001) Regulation of Wnt signaling and
embryo patterning by an extracellular sulfatase. Science 293
(5535), 1663-1666.
17. Sharom FJ, Radeva G. (2004) GPI-anchored protein cleavage
in the regulation of transmembrane signals. Subcell Biochem.
37, 285-315.
18. Pruessmeyer J, Martin C, Hess FM, Schwarz N, Schmidt S,
Kogel T, et al. (2010) A disintegrin and metalloproteinase 17
(ADAM17) mediates inflammation-induced shedding of syn-
decan-1 and -4 by lung epithelial cells. J. Biol. Chem. 285(1),
555-564.
19. Barash U, Cohen-Kaplan V, Dowek I, Sanderson RD, Ilan N,
Vlodavsky I. (2010) Proteoglycans in health and disease: new
concepts for heparanase function in tumor progression and
metastasis. FEBS J. 277(19), 3890-3903.
20. Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M,
Gallagher J, et al. (2006) HSulf-2, an extracellular endoglucos-
amine-6-sulfatase, selectively mobilizes heparin-bound
growth factors and chemokines: effects on VEGF, FGF-1,
and SDF-1. BMC Biochem. 72.
21. Xian X, Gopal S, Couchman JR. (2010) Syndecans as receptors
and organizers of the extracellular matrix. Cell Tissue Res.
339(1), 31-46.
22. Li Q, Esper RM, Loeb JA. (2004) Synergistic effects of
neuregulin and agrin on muscle acetylcholine receptor expres-
sion. Mol. Cell Neurosci. 26(4), 558-569.
23. Kaur C, Sivakumar V, Yip GW, Ling EA. (2009) Expression of
syndecan-2 in the amoeboid microglial cells and its involve-
ment in inflammation in the hypoxic developing brain. Glia
57(3), 336-349.
24. Kato M, Wang H, Bernfield M, Gallagher JT, Turnbull JE.
(1994) Cell surface syndecan-1 on distinct cell types differs in
fine structure and ligand binding of its heparan sulfate chains.
J. Biol. Chem 269(29), 18881-18890.
25. Ledin J, Staatz W, Li JP, Gotte M, Selleck S, Kjellen L, et al.
(2004) Heparan sulfate structure in mice with genetically
modified heparan sulfate production.
26. Kjellen L. (2003) Glucosaminyl N-deacetylase/N-sulphotrans-
ferases in heparan sulphate biosynthesis and biology. Biochem.
Soc. Trans. 31(2), 340-342.
27. van den Born J, Salmivirta K, Henttinen T, Ostman N, Ishimaru
T, Miyaura S, et al. (2005) Novel heparan sulfate structures
revealed by monoclonal antibodies. J. Biol. Chem. 280(21),
20516-20523.
28. Sadir R, Imberty A, Baleux F, Lortat-Jacob H. (2004) Heparan
sulfate/heparin oligosaccharides protect stromal cell-derived
factor-1 (SDF-1)/CXCL12 against proteolysis induced by
CD26/dipeptidyl peptidase IV. J. Biol. Chem. 279(42),
43854-43860.
29. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML,
Lincecum J, et al. (1999) Functions of cell surface heparan
sulfate proteoglycans. Annu. Rev. Biochem. 68, 729-777.
30. Bourin MC, Lindahl U. (1993). Glycosaminoglycans and
the regulation of blood coagulation. Biochem. J. 289(Pt 2),
313-330.
31. Mohammadi M, Olsen SK, Ibrahimi OA. (2005) Structural
basis for fibroblast growth factor receptor activation. Cytokine
Growth Factor Rev. 16(2), 107-137.
32. Friedl A, Filla M, Rapraeger AC. (2001) Tissue-specific
binding by FGF and FGF receptors to endogenous heparan
sulfates. Methods Mol. Biol. 171, 535-546.
33. Forsten-Williams K, Chua CC, Nugent MA. (2005) The kinet-
ics of FGF-2 binding to heparan sulfate proteoglycans and
MAP kinase signaling. J. Theor. Biol. 233(4), 483-499.
34. Lortat-Jacob H, Baltzer F, Grimaud JA. (1996) Heparin
decreases the blood clearance of interferon-gamma and
increases its activity by limiting the processing of its car-
boxyl-terminal sequence. J. Biol. Chem. 271(27), 16139-
16143.
35. Zhong X, Desilva T, Lin L, Bodine P, Bhat RA, Presman E,
et al. (2007) Regulation of secreted Frizzled-related protein-1
by heparin. J. Biol. Chem. 282(28), 20523-20533.
36. Rostand KS, Esko JD. (1997) Microbial adherence to and
invasion through proteoglycans. Infect. Immun. 65(1), 1-8.
37. Shworak NW, Liu J, Petros LM, Zhang L, Kobayashi M,
Copeland NG, et al. (1999) Multiple isoforms of heparan
sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, char-
acterization, and expression of human cdnas and identification
of distinct genomic loci. J. Biol. Chem. 274(8), 5170-5184.
38. Sinha BK. (1975) Renal amyloidosis in the buffalo (a case
report). Indian J. Pathol. Microbiol. 18(2), 110-111.
39. Mochizuki H, Yoshida K, Shibata Y, Kimata K. (2008) Tetra-
sulfated disaccharide unit in heparan sulfate: enzymatic for-
mation and tissue distribution. J. Biol. Chem. 283(45), 31237-
31245.
40. Kern A, Schmidt K, Leder C, Muller OJ, Wobus CE, Bettinger
K, et al. (2003) Identification of a heparin-binding motif on
adeno-associated virus type 2 capsids. J. Virol. 77(20), 11072-
11081.
41. Vandenberghe LH, Wang L, Somanathan S, Zhi Y, Figueredo J,
Calcedo R, et al. (2006) Heparin binding directs activation of T
cells against adeno-associated virus serotype 2 capsid. Nat.
Med. 12(8), 967-971.
J. Biol. Chem.
279(41), 42732-42741.
Search WWH ::
Custom Search